Page 103 - v11i4

International Journal of Bioprinting Printed organoids for medicine

151. Li Y, Liu J, Xu S, Wang J. 3D bioprinting: an important tool 162. Chen H, Wu Z, Gong Z, et al. Acoustic bioprinting of
for tumor microenvironment research. Int J Nanomed. patient-derived organoids for predicting cancer therapy
2023;18:8039-8057. responses. Adv Healthc Mater. 2022;11(13):2102784.
doi: 10.2147/ijn.S435845 doi: 10.1002/adhm.202102784
152. Heinrich MA, Bansal R, Lammers T, Zhang YS, Michel 163. Choi Y-m, Lee H, Ann M, Song M, Rheey J, Jang J. 3D
Schiffelers R, Prakash J. 3D-bioprinted mini-brain: bioprinted vascularized lung cancer organoid models with
a glioblastoma model to study cellular interactions underlying disease capable of more precise drug evaluation.
and therapeutics. Adv Mater (Deerfield Beach, Fla). Biofabrication. 2023;15(3):034104.
2019;31(14):e1806590. doi: 10.1088/1758-5090/acd95f
doi: 10.1002/adma.201806590 164. Jungeun K, Hoe Suk K, Ga Yeon K, et al. Abstract P5-02-
153. Zhou X, Zhu W, Nowicki M, et al. 3D bioprinting a cell- 02: development of automated 3d high-throughput drug
laden bone matrix for breast cancer metastasis study. ACS screening platform for patient-derived breast cancer
Appl Mater Interfaces. 2016;8(44):30017-30026. organoids. Cancer Res. 2022;82:2.
doi: 10.1021/acsami.6b10673 doi: 10.1158/1538-7445.sabcs21-p5-02-02
154. Hughes AM, Kolb AD, Shupp AB, Shine KM, Bussard 165. Hou S, Tiriac H, Sridharan BP, et al. Advanced development
KM. Printing the pathway forward in bone metastatic of primary pancreatic organoid tumor models for high-
cancer research: applications of 3D engineered models and throughput phenotypic drug screening. SLAS Discov.
bioprinted scaffolds to recapitulate the bone-tumor niche. 2018;23(6):574-584.
Cancers (Basel). 2021;13(3):507. doi: 10.1177/2472555218766842
doi: 10.3390/cancers13030507 166. Arutyunyan I, Jumaniyazova E, Makarov A, Fatkhudinov T.
155. Mazzocchi A, Soker S, Skardal A. 3D bioprinting for high- In vitro models of head and neck cancer: from primitive to
throughput screening: drug screening, disease modeling, most advanced. J Pers Med. 2023;13(11):1575.
and precision medicine applications. Appl Phys Rev. doi: 10.3390/jpm13111575
2019;6(1):011302. 167. Azhakesan A, Kern J, Mishra A, et al. 3D bioprinted head
doi: 10.1063/1.5056188 and neck squamous cell carcinoma (HNSCC) model using
156. Kim J, Jang J, Cho D-W. Recapitulating the cancer tunicate derived nanocellulose (NC) bioink. Adv Healthc
microenvironment using bioprinting technology for Mater. 2025;14(7):e2403114.
precision medicine. Micromachines. 2021;12(9):1122. doi: 10.1002/adhm.202403114
doi: 10.3390/mi12091122 168. Baka Z, Godier C, Lamy L, et al. A coculture based,
157. Langer EM, Allen-Petersen BL, King SM, et al. Modeling 3D bioprinted ovarian tumor model combining cancer
tumor phenotypes in vitro with three-dimensional cells and cancer associated fibroblasts. Macromol Biosci.
bioprinting. Cell Rep. 2019;26(3):608-623.e6. 2023;23(3):e2200434.
doi: 10.1016/j.celrep.2018.12.090 doi: 10.1002/mabi.202200434
158. Calandrini C, Drost J. Normal and tumor-derived organoids 169. Tebon PJ, Wang B, Markowitz AL, et al. Drug screening
as a drug screening platform for tumor-specific drug at single-organoid resolution via bioprinting and
vulnerabilities. STAR Protoc. 2022;3(1):101079. interferometry. Nat Commun. 2023;14(1):3168.
doi: 10.1016/j.xpro.2021.101079 doi: 10.1038/s41467-023-38832-8
159. Wu P, Asada H, Hakamada M, Mabuchi M. Bioengineering 170. Nhan P, Jenny JH, Bobby T, et al. A simple high-throughput
of high cell density tissues with hierarchical vascular approach identifies actionable drug sensitivities in patient-
networks for ex vivo whole organs. Adv Mater (Deerfield derived tumor organoids. Commun Biol. 2019;2(1):1.
Beach, Fla). 2023;35(9):e2209149. doi: 10.1038/s42003-019-0305-x
doi: 10.1002/adma.202209149 171. Krendl FJ, Primavesi F, Oberhuber R, et al. The importance of
160. Bjerring JS, Khodour Y, Peterson EA, Sachs PC, Bruno preclinical models for cholangiocarcinoma drug discovery.
RD. Intercellular mitochondrial transfer contributes to Expert Opin Drug Discov. 2025;20(2):205-216.
microenvironmental redirection of cancer cell fate. FEBS J. doi: 10.1080/17460441.2025.2457637
2025;292(9):2306-2322. 172. Joshi P, Nascimento HSD, Kang SY, et al. Dynamic culture
doi: 10.1111/febs.70002 of bioprinted liver tumor spheroids in a pillar/perfusion
plate for predictive screening of anticancer drugs. Biotechnol
161. Khan AO, Rodriguez-Romera A, Reyat JS, et al. Human
bone marrow organoids for disease modeling, discovery, Bioeng. 2025;122(4):995-1009.
and validation of therapeutic targets in hematologic doi: 10.1002/bit.28924
malignancies. Article. Cancer Discov. 2023;13(2):364-385. 173. Kalla J, Pfneissl J, Mair T, Tran L, Egger G. A systematic
doi: 10.1158/2159-8290.Cd-22-0199 review on the culture methods and applications of 3D

Volume 11 Issue 4 (2025) 95 doi: 10.36922/IJB025190184